FMC Corp

FMC is entrenched in a Stage 4 decline with price below all major EMAs and a dominant Lower Highs & Lower Lows pattern indicating ongoing supply dominance. Under a Speculative strategy, only bearish engagement is permitted; short-term price is being rejected at the declining 9- and 21-day EMAs, providing a clear timing edge to sell into resistance now.

• ↑Sales of new actives (e.g., Isoflex) doubled YoY in Q1
• ↑2026 FCF forecast of –$65M to $65M, earmarked for debt
• ↓Profitability severely negative, lower grower margins boost generics